Cargando…

Creating R&D Incentives for Medicines for Neglected Diseases An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research /

Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank Müller-Langer addresses the market failure with respect to R&D for medicines for tropical dise...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Müller-Langer, Frank (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Wiesbaden : Gabler Verlag : Imprint: Gabler Verlag, 2009.
Edición:1st ed. 2009.
Colección:Ökonomische Analyse des Rechts
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-8349-8323-7
003 DE-He213
005 20220118195744.0
007 cr nn 008mamaa
008 100301s2009 gw | s |||| 0|eng d
020 |a 9783834983237  |9 978-3-8349-8323-7 
024 7 |a 10.1007/978-3-8349-8323-7  |2 doi 
050 4 |a RA410-410.9 
072 7 |a KCQ  |2 bicssc 
072 7 |a BUS069000  |2 bisacsh 
072 7 |a KCVJ  |2 thema 
082 0 4 |a 338.4761  |2 23 
100 1 |a Müller-Langer, Frank.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Creating R&D Incentives for Medicines for Neglected Diseases  |h [electronic resource] :  |b An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research /  |c by Frank Müller-Langer. 
250 |a 1st ed. 2009. 
264 1 |a Wiesbaden :  |b Gabler Verlag :  |b Imprint: Gabler Verlag,  |c 2009. 
300 |a XIX, 297 p. 8 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Ökonomische Analyse des Rechts 
505 0 |a The TRIPS Agreement and Access to Patented Medicines -- Economic Analysis of Patents -- Patent Protection in the Developing World: Theory and Evidence -- Legal and Economic Analysis of Parallel Imports -- Solutions for the Problem of Underinvestment in R&D for Medicines for Neglected Infectious and Tropical Diseases -- Conclusion and Ideas for Further Research. 
520 |a Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank Müller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country's perspective. 
650 0 |a Medical economics. 
650 0 |a Technological innovations. 
650 1 4 |a Health Economics. 
650 2 4 |a Innovation and Technology Management. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783834917300 
830 0 |a Ökonomische Analyse des Rechts 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-8349-8323-7  |z Texto Completo 
912 |a ZDB-2-SBE 
912 |a ZDB-2-SXEF 
950 |a Business and Economics (SpringerNature-11643) 
950 |a Economics and Finance (R0) (SpringerNature-43720)